LITTLE FALLS, N.J.,
March 6, 2013 /PRNewswire/
-- Cantel Medical Corp. (NYSE: CMN), a leading provider
of infection prevention and control products, has officially
launched RAPICIDE OPA/28, an ortho-phthalaldehyde (OPA)
based high-level disinfectant for semi-critical medical devices, to
multiple segments of the healthcare market. A 510(k) cleared
product by the FDA, RAPICIDE OPA/28 high-level disinfectant offers
a reuse period for up to 28 days, twice the reuse life among all
OPA-based disinfectants available on the market, and the fastest
manual disinfection time at ten minutes at room temperature.
"We are very pleased to offer our latest disinfection product to
broad segments of the healthcare market," said Andrew Krakauer, President and CEO, Cantel
Medical Corp. "With close attention to healthcare cost control,
increased scrutiny over healthcare-associated infections (HAIs),
and higher demand for quality of care, we are excited that RAPICIDE
OPA/28 high-level disinfectant is capable of lowering overall
reprocessing costs among OPA-based disinfectants while delivering
excellent product performance that will enhance the patients' and
healthcare workers' use experience."
"Our expertise in infection control and prevention has enabled
our success in bringing instrument disinfection technology to the
next level," added Jorgen Hansen,
Executive Vice President and COO, Cantel Medical Corp. "The launch
of RAPICIDE OPA/28 high-level disinfectant is a clear milestone
that demonstrates our ability to develop infection control
solutions to broader healthcare markets."
RAPICIDE OPA/28 is a convenient, ready-to-use high-level
disinfectant designed for use in central processing departments,
gastrointestinal departments, surgery centers, physician offices,
and other areas where high-level disinfection is required. It can
disinfect a wide range of endoscopes and other heat sensitive
semi-critical medical devices. The product will be produced and
sold via Cantel Medical Corp.'s subsidiaries: MEDIVATORS Inc.
(www.medivators.com), Crosstex International (www.crosstex.com),
and SPSmedical (www.spsmedical.com).
About Cantel Medical Corp.
Cantel Medical Corp. (NYSE:
CMN) is a leading provider of infection prevention and control
products in the healthcare market. Our products include water
purification equipment, sterilants, disinfectants and cleaners,
specialized medical device reprocessing systems for endoscopy and
renal dialysis, disposable infection control products primarily for
dental and GI endoscopy markets, dialysate concentrates and other
dialysis supplies, hollow fiber membrane filtration and separation
products for medical and non-medical applications, and specialty
packaging for infectious and biological specimens. We also provide
technical maintenance for our products and offer compliance
training services for the transport of infectious and biological
specimens.
SOURCE Cantel Medical Corp.